Results 161 to 170 of about 9,317 (205)

Enhanced Plasma Stability and Potency of Aryl/Acyloxy Prodrugs of a BTN3A1 Ligand. [PDF]

open access: yesACS Med Chem Lett
Singh U   +5 more
europepmc   +1 more source

Discovery of a PDE4B and PDE4D selective bifunctional degrader for management of chronic inflammatory disorders. [PDF]

open access: yesJ Transl Autoimmun
Shakya A   +16 more
europepmc   +1 more source

An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. [PDF]

open access: yesJ Med Chem
Fabbrizi E   +8 more
europepmc   +1 more source

Drug Discovery Strategies for Kallikrein-Related Peptidases. [PDF]

open access: yesInt J Mol Sci
Dreyer T   +3 more
europepmc   +1 more source

Discovery of a Non-competitive TNFR1 Antagonist Affibody with Picomolar Monovalent Potency That Does Not Affect TNFR2 Function

Molecular Pharmaceutics, 2023
Tumor necrosis factor (TNF) is a key regulator of immune responses and plays a significant role in the initiation and maintenance of inflammation. Upregulation of TNF expression leads to several inflammatory diseases, such as Crohn's, ulcerative colitis, and rheumatoid arthritis.
Nagamani Vunnam   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy